News

1. Pierre Fabre, founded in 1962 by Pierre Fabre, is the second largest privately owned pharmaceutical company in France, with two business divisions: medical skin cosmetics and pharmaceuticals. In 2023, Pierre Fabre's turnover reached 2.83 billion euros, 70% of which came from 120 countries around the world, and more than 190 million euros were invested in research and development. Pierre Fabre Laboratories is always located in the Oxitane region of France, 90% of its products are produced in France, and it employs nearly 9,600 people worldwide. 86% of the shares of Pierre Fabre Laboratories are owned by the Pierre Fabre Foundation, which since 1999 has been regarded as a public utility foundation and seconded by its employees through an employee stock ownership plan.

2. In September 2023, Pierre Fabre Laboratories, through its investment subsidiary Pierre Fabre Invest, acquired a minority stake in MiYe, a French startup company specializing in skin care products and dietary supplements that enhance the hormonal balance and well-being of women.

3. In 2024, Clinical Skin announced the acquisition of Glytone, a brand of fruit acid skin care brand owned by Pierre Faber, a French pharmaceutical and cosmetics group.

4. In the pharmaceutical segment, which focuses on cancer care and chronic care, other healthcare brands and products also include: Pierre Fabre Healthcare, which includes helping families prevent, relieve and treat everyday illnesses, brands Drill, Dexeryl, Nicopass, NiopatchLib, Cicatryl, Carbolevure, Structum, PediRelax and more.

5. Plant Nutrition and health care brands :Naturactive, Pierre Fabre Oral Care: including INAVA, ELGYDIUM, Eluday and ARTHRODONT.